دورية أكاديمية
A phase II study of induction followed by intermittent duvelisib dosing in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
| العنوان: | A phase II study of induction followed by intermittent duvelisib dosing in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). |
|---|---|
| المؤلفون: | Shouse G; City of Hope National Medical Center, CA, USA., Chen L; City of Hope National Medical Center, CA, USA., Siddiqi T; City of Hope National Medical Center, CA, USA., Muir A; City of Hope National Medical Center, CA, USA., Brown JR; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Spurgeon SE; The Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA., Danilov AV; City of Hope National Medical Center, CA, USA. |
| المصدر: | Leukemia & lymphoma [Leuk Lymphoma] 2024 Jun 05, pp. 1-4. Date of Electronic Publication: 2024 Jun 05. |
| Publication Model: | Ahead of Print |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: [Philadelphia, PA] : Taylor & Francis Original Publication: Chur ; New York : London, UK : Harwood Academic Publishers ; Distributed by STBS, 1989- |
| فهرسة مساهمة: | Keywords: CLL; ClinicalTrials.gov identifier: NCT03961672; PI3K; chronic lymphocytic leukemia; duvelisib |
| تواريخ الأحداث: | Date Created: 20240605 Latest Revision: 20240605 |
| رمز التحديث: | 20240605 |
| DOI: | 10.1080/10428194.2024.2361841 |
| PMID: | 38836342 |
| قاعدة البيانات: | MEDLINE |
PDF full text from Publisher | تدمد: | 1029-2403 |
|---|---|
| DOI: | 10.1080/10428194.2024.2361841 |